RP Management, LLC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 240 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 1.6%.

Quarter-by-quarter ownership
RP Management, LLC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$167,967,000
+3.7%
1,111,1110.0%77.60%
+21.4%
Q2 2022$161,900,000
+22.9%
1,111,1110.0%63.94%
+19.3%
Q1 2022$131,744,000
-14.0%
1,111,1110.0%53.58%
-16.4%
Q4 2021$153,122,000
-0.8%
1,111,1110.0%64.09%
-11.0%
Q3 2021$154,344,000
+43.1%
1,111,1110.0%72.03%
+37.0%
Q2 2021$107,867,000
-25.2%
1,111,111
-47.4%
52.60%
-2.9%
Q1 2021$144,294,000
-20.3%
2,111,1110.0%54.16%
-2.4%
Q4 2020$180,943,000
+31.8%
2,111,1110.0%55.51%
+169.9%
Q3 2020$137,243,000
-11.1%
2,111,1110.0%20.57%
-31.1%
Q2 2020$154,343,000
+114.8%
2,111,1110.0%29.83%
+33.8%
Q1 2020$71,841,000
-37.5%
2,111,1110.0%22.30%
-14.2%
Q4 2019$114,923,000
+30.5%
2,111,1110.0%25.98%
-53.9%
Q3 2019$88,076,000
-4.7%
2,111,1110.0%56.42%
-0.5%
Q2 2019$92,446,000
-14.9%
2,111,1110.0%56.70%
+4.3%
Q1 2019$108,659,000
+39.2%
2,111,1110.0%54.35%
+1.7%
Q4 2018$78,069,0002,111,11153.45%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q3 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 900,844$136,181,00079.57%
RP Management, LLC 1,111,111$167,967,00077.60%
JET CAPITAL INVESTORS L P 1,707,500$258,942,00053.95%
Alpine Global Management, LLC 373,999$56,537,00013.23%
Chicago Capital Management, LLC 154,585$23,443,00012.75%
FIFTH LANE CAPITAL, LP 140,000$21,164,00011.03%
UBS OCONNOR LLC 3,784,482$572,100,000,00010.85%
Eversept Partners, LP 637,139$96,316,3038.35%
EQUITEC PROPRIETARY MARKETS, LLC 187,100$28,284,0007.45%
HARVEST MANAGEMENT LLC 48,503$7,332,0005.92%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders